A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

Clinical trial NCT03199339 · COMPLETED

Trial details

NCT number: NCT03199339
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tuberculosis Tuberculosis, Pulmonary

Start date: 2017-08-29
Primary completion: 2018-07-08
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.